As a client-focused, solution-oriented, enthusiastic and insightful leader with global bio-pharma experience, and Accencio's President and CEO, Kevin is dedicated to identifying and delivering strategic value to our clients through our cutting edge technology and services and realizing the Accencio vision and mission.
Kevin is the scientific leader of Accencio and is responsible for the creation of our range of cutting edge technologies. Kevin brings his broad experience in the bio-pharmaceutical industry to enable the Accencio vision, and through his support and strategic product development has provided the framework for the future success of Accencio.
As our CIO, Mike is responsible for overseeing all aspects of our information technology and security, data and analytics. Mike brings his bio-pharmaceutical IT experience, energy and enthusiasm to the leadership of the continued development of our unique, secure, robust and cutting edge information technology systems.
Richard is dedicated to developing, communicating, executing, and sustaining our strategic vision and direction to enable Accencio to create, drive and achieve sustainable long term growth and success. A creative thinker and influential collaborator, Richard helps Kevin and Kevin steer the ship keeping their eyes on the vision and mission.
Emma brings an unstoppable enthusiasm for change and improvement to Accencio. Emma has dedicated her career to turning her natural disinclination to accept the status quo into a drive for improvement in international business analysis, project and change management across continents, industry verticals and regulatory environments.
The latest addition to our Accencio team, Rhonda brings a wealth of strategic, financial, and business development planning and analysis expertise, along with extensive experience in the venture capital and M&A within large and emerging biopharma and health care companies, helping us reach the next level and achieve our ambitious goals.